http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102796118-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df43396cf3f9917218a854da45947614 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c4983385ab31075069db48d5cc0d792 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_294460b6bd086521fcdc3d9a0bf7255d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bafc52c98d7abd4f92b9945f4341171a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c36e3f72a11a35d8757f9e157efeec2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84f60ba9b0cae84e47193e0331221bea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_725a41e5d3ba8bea80bcd5361aac34bf |
| publicationDate | 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102796118-B |
| titleOfInvention | Cefodizime sodium compound solid, method for preparing same and pharmaceutical preparation of cefodizime sodium compound solid |
| abstract | The invention discloses a cefodizime sodium compound solid, a method for preparing the same and a pharmaceutical preparation of the cefodizime sodium compound solid, wherein the method for preparing the cefodizime sodium compound solid comprises the following steps of: first, dissolving crude cefodizime sodium salt in an acetone aqueous solution, then adding activated carbon to adsorb and filter, cooling the filtrate, stirring to separate the solid out, adding an acetone solvent to separate the solid out, filtering and drying, thus obtaining the cefodizime sodium compound solid. The prepared compound solids are fine particles, and have uniform particle size distribution and good liquidity, the crystallization technology is simple, the residual amount of organic solvent is low, and the product stability and pharmaceutical safety are effectively improved. |
| priorityDate | 2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.